MoneyWorks4Me

Biofil Chem & Pharma - Quaterly Results

13 Aug 2024 Evaluate
An increase of about 246.88% to Rs. 84.43 millions in the total revenue was observed for the quarter ended June 2024. The total revenue was pegged at Rs. 24.34 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 1.69 millions from Rs. 2.44 millions, a decline of -30.74% on QoQ basis.A decline of 3.38 millions was observed in the OP in the quarter ended June 2024 from 4.42 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 84.43 24.34 246.88 84.43 24.34 246.88 400.35 300.35 33.29
Other Income 0.29 0.25 16.00 0.29 0.25 16.00 4.90 0.97 405.15
PBIDT 3.38 4.42 -23.53 3.38 4.42 -23.53 13.06 12.65 3.24
Interest 0.11 0.11 0.00 0.11 0.11 0.00 0.42 0.43 -2.33
PBDT 3.27 4.31 -24.13 3.27 4.31 -24.13 12.64 12.22 3.44
Depreciation 0.99 1.07 -7.48 0.99 1.07 -7.48 3.99 4.29 -6.99
PBT 2.28 3.24 -29.63 2.28 3.24 -29.63 8.65 7.93 9.08
TAX 0.59 0.80 -26.25 0.59 0.80 -26.25 1.56 2.33 -33.05
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.84 0.03 -2900.00
PAT 1.69 2.44 -30.74 1.69 2.44 -30.74 7.09 5.60 26.61
Equity 162.74 162.74 0.00 162.74 162.74 0.00 162.74 162.74 0.00
PBIDTM(%) 4.00 18.16 -77.95 4.00 18.16 -77.95 3.26 4.21 -22.55
Peers